Health
Australian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients – Monash University
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support…
05 August 2021
Full-dose anticoagulation with the blood thinner heparin improves survival outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill COVID-19 patients, but does not yield the same positive outcomes…
Continue Reading
-
Noosa News24 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News21 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit
-
General23 hours agoPeter Dutton partially walks back public service work-from-home vow